Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

China's National Joint Procurement Office Disqualifies Eugia Pharma and JSC "Farmak" Over Supply Failures – Four‑Year and Two‑Year Bans Imposed Under Centralized Drug Procurement Rules
Policy / Regulatory

China’s National Joint Procurement Office Disqualifies Eugia Pharma and JSC “Farmak” Over Supply Failures – Four‑Year and Two‑Year Bans Imposed Under Centralized Drug Procurement Rules

The National Joint Procurement Office for Drugs announced that two selected companies in China's national centralized drug procurement program have been disqualified and placed on the "violation list" after failing…

Xiangxue Pharma's XLS-103 Wins NMPA Clinical Trial Approval for KRAS G12V–Positive Advanced Colorectal Cancer – Proprietary TCR-T Cell Therapy Expands to Third Tumor Type in China

Xiangxue Pharma’s XLS-103 Wins NMPA Clinical Trial Approval for KRAS G12V–Positive Advanced Colorectal Cancer – Proprietary TCR-T Cell Therapy Expands to Third Tumor Type in China

Innovent's Sintilimab Plus Nogileucel (GC101) Melanoma NDA Accepted by NMPA – Backed by 57% Progression Risk Reduction in MIZAR-003

Innovent’s Sintilimab Plus Nogileucel (GC101) Melanoma NDA Accepted by NMPA – Backed by 57% Progression Risk Reduction in MIZAR-003

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Hengrui's HER2-Targeted ADC and Antibody Drug Combo Approved for Trials
CompanyDrug

Hengrui’s HER2-Targeted ADC and Antibody Drug Combo Approved for Trials

CSPC's SYS 6043 Receives FDA Approval for Clinical Trials
CompanyDrug

CSPC’s SYS 6043 Receives FDA Approval for Clinical Trials

Wepon Medical's WP107 Receives FDA Approval for gMG Clinical Trial
CompanyDrug

Wepon Medical’s WP107 Receives FDA Approval for gMG Clinical Trial

Fosun Pharma Initiates Phase II Study for Glomerular Disease Treatment
CompanyDrug

Fosun Pharma Initiates Phase II Study for Glomerular Disease Treatment

Hengrui's SHR-9839 Receives NMPA Clearance for Advanced Tumors
CompanyDrug

Hengrui’s SHR-9839 Receives NMPA Clearance for Advanced Tumors

Huadong Medicine Gets FDA Nod for Phase I Study of HDM2006 in Solid Tumors
CompanyDrug

Huadong Medicine Gets FDA Nod for Phase I Study of HDM2006 in Solid Tumors

Tonghua Dongbao Begins Phase II Trial for GLP-1/GIP Agonist THDBH120 in Weight Loss
CompanyDrug

Tonghua Dongbao Begins Phase II Trial for GLP-1/GIP Agonist THDBH120 in Weight Loss

CSPC Pharmaceutical's ADC Pipeline Advances with SYS 6041 Approval
CompanyDrug

CSPC Pharmaceutical’s ADC Pipeline Advances with SYS 6041 Approval

Show More